Abbvie Inc (NYSE:ABBV)
| 117.12 BATS BZX Real-Time Price As of 12:38pm ET |  +0.52 / +0.45%Today’s Change | 79.11 Today|||52-Week Range 117.58 | +9.30% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 116.60 |
| Today’s open | 117.54 |
| Day’s range | 116.53 - 117.58 |
| Volume | 2,380,637 |
| Average volume (3 months) | 7,177,759 |
| Market cap | $204.3B |
Data as of 12:38pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | -48.39% |
| Earnings growth (this year) | +18.48% |
| Earnings growth (next 5 years) | +2.85% |
| Revenue growth (last year) | +37.69% |
| P/E ratio | 43.5 |
| Price/Sales | 3.91 |
| Price/Book | 15.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | -0.13 | -0.17% |
| NVSNovartis | +0.57 | +0.64% |
| PFEPfizer | +0.05 | +0.12% |
| LLYEli Lilly and Co | +1.73 | +0.89% |
Data as of 12:38pm ET, 05/14/2021
Financials
| Next reporting date | July 23, 2021 |
| EPS forecast (this quarter) | $3.07 |
| Annual revenue (last year) | $45.8B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 9.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
